Vimarsana
Biggest News Aggregation in the World

Page 9 - Current Reports News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Reports Today - Breaking & Trending Today

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting - Vimarsana News

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting

Molecular Residual Disease study and multiple RiskScore studies among seven new datasets to be shared by Myriad and Collaborators SALT LAKE CITY, May 23, 2024 -- Myriad Genetics, Inc., , a leader...

Trinity Industries, Inc. Announces Pricing of Offering of $200.0 Million of Additional 7.750% Senior Notes Due 2028 - Vimarsana News

Trinity Industries, Inc. Announces Pricing of Offering of $200.0 Million of Additional 7.750% Senior Notes Due 2028

Trinity Industries, Inc. today announced that it has finalized the terms of its offering of an additional $200.0 million aggregate principal amount of its 7.750% Senior Notes due 2028 . Trinity...

Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan - Vimarsana News

Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan

Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's...

VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients - Vimarsana News

VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients

VBI Vaccines Inc. , a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the...

Twin Vee PowerCats Co. Goes All-Digital, Tech-Forward with New GFX2 Models - Vimarsana News

Twin Vee PowerCats Co. Goes All-Digital, Tech-Forward with New GFX2 Models

FORT PIERCE, FL / ACCESSWIRE / May 22, 2024 / Twin Vee PowerCats Co. (Nasdaq:VEEE),("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced that its